Biochemistry Referrals - UHC

Descriptions

Biochemistry referral testing.

VII.1.2) Text to be corrected in the original notice
Section number
VI.3

Instead of
Text
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not appl to this award. The standstill period begins on the day after the publication of this notice.

Representations by providers must be made to decision makers by 29th July 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Decision makers: Dr Kate MacDougall

Conflicts of Interest: None declared

Clinical Criteria: Second Opinion are requested from experts in a chosen speciality that are employed in a UKAS accredited laboratory and participate in EQA for that speciality.

Turnaround times for results are also a consideration for utilising the referral service with this provider. Test referrals are made to UKAS accredited laboratories with acceptable clinical

interpretation, availability of clinical advice and turnarounds that facilitate compliance with RCPath guidelines. Referrals are often made in accordance with established regional referral

pathways in line with MDT arrangements for tertiary specialities. Genomic test referrals are made in accordance with genomic hub guidelines.

Rationale: Existing service provider, will likely satisfy the proposed contract to a sufficient standard. No considerable changes anticipated.

Read
Text
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 4th August 2025. This

contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Decision Makers: Dr David Kennedy

Conflicts of Interest: None declared

Clinical criteria: Suitable / compatible analytical methodology, appropriate reference ranges and clinical comments, availability of useful clinical advice (based on national reputation, and/or experience and/or user feedback)

UKAS Accredited (or ETS applied for and pending assessment)